Yung-Luen Yu Selected Research

Yung-Luen Yu Research Topics

Disease

39	Neoplasms (Cancer) 08/2021 - 05/2009
13	Breast Neoplasms (Breast Cancer) 03/2019 - 12/2006
11	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 02/2010
9	Triple Negative Breast Neoplasms 01/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 04/2021 - 04/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 05/2009
4	Lung Neoplasms (Lung Cancer) 01/2017 - 05/2009
4	Glioblastoma (Glioblastoma Multiforme) 06/2015 - 08/2008
3	Brain Neoplasms (Brain Tumor) 06/2015 - 08/2008
3	Stroke (Strokes) 10/2013 - 04/2013
2	Wounds and Injuries (Trauma) 04/2020 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 06/2015
2	Rheumatoid Arthritis 04/2017 - 09/2014
2	Prostatic Neoplasms (Prostate Cancer) 06/2015 - 07/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2015 - 07/2014
2	Pneumonia (Pneumonitis) 04/2014 - 09/2013
2	Chronic Hepatitis B 01/2014 - 01/2012
1	Nasopharyngeal Carcinoma 04/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Cough 01/2018
1	Chondrosarcoma 01/2018
1	Glioma (Gliomas) 01/2018
1	Pain (Aches) 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2017
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2017
1	Mouth Neoplasms (Oral Cancer) 05/2016
1	Leukemia 06/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2012
5	ErbB Receptors (EGF Receptor)IBA 07/2014 - 07/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
4	MicroRNAs (MicroRNA)IBA 07/2020 - 12/2013
4	Estrogen ReceptorsIBA 01/2020 - 03/2011
4	human ERBB2 proteinIBA 01/2020 - 04/2013
4	Ribonucleases (Ribonuclease)IBA 06/2015 - 03/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 11/2013
3	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 09/2014
3	Histones (Histone)IBA 01/2018 - 07/2014
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 09/2013
3	Peptides (Polypeptides)IBA 01/2017 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2014 - 04/2011
3	Interleukin-15 (Interleukin 15)IBA 05/2012 - 05/2009
2	praeruptorin AIBA 04/2021 - 04/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2016
2	Enhancer of Zeste Homolog 2 ProteinIBA 07/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2017 - 09/2014
2	TubulinIBA 01/2016 - 06/2015
2	DNA-Activated Protein KinaseIBA 06/2015 - 09/2012
2	Phosphotransferases (Kinase)IBA 06/2015 - 04/2013
2	Caspase 9IBA 06/2015 - 09/2014
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2014 - 01/2013
2	Polysaccharides (Glycans)IBA 01/2014 - 01/2012
2	Tyrosine Kinase InhibitorsIBA 11/2013 - 04/2011
2	Lapatinib (GW572016)FDA Link 11/2013 - 04/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013 - 12/2006
2	Epidermal Growth Factor (EGF)IBA 09/2010 - 07/2009
2	butylidenephthalideIBA 02/2010 - 08/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2021
1	capsanthinIBA 01/2021
1	Chemokine ReceptorsIBA 07/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2020
1	salvianolic acid AIBA 04/2020
1	anomalinIBA 04/2020
1	praeruptorin CIBA 04/2020
1	Hormones (Hormone)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	mangostinIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	LycopeneIBA 01/2020
1	Succinic Acid (Succinate)IBA 03/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2019
1	Vitamin E FDA LinkGeneric 03/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 01/2019
1	alpha-Tocopherol FDA Link 01/2019
1	Cyclin B1IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	aristolochic acid I (aristolochic acid)IBA 01/2018
1	Polycomb Repressive Complex 2IBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	BAY 11-7085IBA 01/2018
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 04/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Vascular Endothelial Growth Factor CIBA 01/2017
1	InflammasomesIBA 01/2017
1	Nicotine FDA Link 01/2017
1	Environmental CarcinogensIBA 05/2016
1	gallocatechol (epigallocatechin)IBA 03/2016
1	sulforaphaneIBA 03/2016
1	Checkpoint Kinase 1IBA 06/2015
1	Checkpoint Kinase 2IBA 06/2015

Therapy/Procedure

10	Therapeutics 01/2021 - 05/2009
5	Immunotherapy 08/2021 - 05/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
3	Radiotherapy 07/2014 - 09/2012